Cargando…
Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus
Autores principales: | Patrick, David M., de la Visitación, Néstor, Krishnan, Jaya, Chen, Wei, Ormseth, Michelle J., Stein, C. Michael, Davies, Sean S., Amarnath, Venkataraman, Crofford, Leslie J., Williams, Jonathan M., Zhao, Shilin, Smart, Charles D., Dikalov, Sergey, Dikalova, Anna, Xiao, Liang, Van Beusecum, Justin P., Ao, Mingfang, Fogo, Agnes B., Kirabo, Annet, Harrison, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462492/ http://dx.doi.org/10.1172/jci.insight.163757 |
Ejemplares similares
-
Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus
por: Patrick, David M., et al.
Publicado: (2022) -
Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation
por: Mayorov, Vladimir, et al.
Publicado: (2019) -
Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation
por: Ruggeri Barbaro, Natalia, et al.
Publicado: (2020) -
Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity
por: Aggarwal, Geetika, et al.
Publicado: (2021) -
Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension
por: Prinsen, Joseph K., et al.
Publicado: (2020)